We are live on ! Find out more
NME

Notis-McConarty Edward Portfolio holdings

AUM $201M
1-Year Est. Return 18.67%
This Fund
S&P 500
This Quarter Est. Return
+5.3%
1 Year Est. Return
+18.67%
3 Year Est. Return
+65.19%
5 Year Est. Return
+89.79%
10 Year Est. Return
+322.21%
AUM
$146M
AUM Growth
+$4.19M
Cap. Flow
-$2.13M
Cap. Flow %
-1.46%
Top 10 Hldgs %
30.9%
Holding
120
New
4
Increased
17
Reduced
19
Closed
5

Top Buys

Rank Stock Value
1
CDK
CDK Global, Inc.
CDK
+$569K
2
HP icon
Helmerich & Payne
HP
+$280K
3
XYL icon
Xylem
XYL
+$272K
4
RTX icon
RTX Corp
RTX
+$222K
5
TXN icon
Texas Instruments
TXN
+$207K

Top Sells

Rank Stock Value
1
GSK icon
GSK
GSK
+$1.8M
2
XOM icon
ExxonMobil
XOM
+$706K
3
ADP icon
Automatic Data Processing
ADP
+$468K
4
QCOM icon
Qualcomm
QCOM
+$325K
5
LH icon
Labcorp
LH
+$278K

Sector Composition

Rank Sector Weight
1 Healthcare 22.96%
2 Technology 21.99%
3 Industrials 17.97%
4 Energy 9.95%
5 Consumer Staples 9.28%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
JNJ icon
1
Johnson & Johnson
JNJ
$645B
$6.01M 4.11%
57,483
+252
+0.4% +$26.6K
PG icon
2
Procter & Gamble
PG
$347B
$5.33M 3.65%
58,551
+75
+0.1% +$6.6K
INTC icon
3
Intel
INTC
$460B
$5.22M 3.57%
143,752
– –
XOM icon
4
ExxonMobil
XOM
$642B
$4.67M 3.19%
50,487
-7,574
-13% -$706K
MMM icon
5
3M
MMM
$91.1B
$4.47M 3.06%
32,573
– –
CVS icon
6
CVS Health
CVS
$137B
$4.39M 3%
45,543
+150
+0.3% +$13.2K
ADP icon
7
Automatic Data Processing
ADP
$103B
$4.16M 2.85%
49,957
-5,777
-10% -$468K
RTX icon
8
RTX Corp
RTX
$297B
$3.9M 2.67%
53,851
+3,257
+6% +$222K
EMR icon
9
Emerson Electric
EMR
$83B
$3.35M 2.29%
54,194
+847
+2% +$53.1K
ABT icon
10
Abbott
ABT
$183B
$3.16M 2.16%
70,145
+2,700
+4% +$118K
MA icon
11
Mastercard
MA
$488B
$2.96M 2.03%
34,395
+305
+0.9% +$24.9K
MSFT icon
12
Microsoft
MSFT
$2.92T
$2.96M 2.02%
63,637
– –
NVS icon
13
Novartis
NVS
$298B
$2.8M 1.91%
33,705
+1,646
+5% +$136K
CVX icon
14
Chevron
CVX
$381B
$2.77M 1.89%
24,672
-450
-2% -$51.1K
QCOM icon
15
Qualcomm
QCOM
$178B
$2.74M 1.87%
36,840
-4,445
-11% -$325K
ATR icon
16
AptarGroup
ATR
$8.51B
$2.73M 1.87%
40,875
+1,750
+4% +$111K
CSCO icon
17
Cisco
CSCO
$451B
$2.63M 1.8%
94,585
-100
-0.1% -$2.58K
ABBV icon
18
AbbVie
ABBV
$457B
$2.62M 1.79%
40,105
– –
IBM icon
19
IBM
IBM
$205B
$2.6M 1.78%
16,955
– –
CNI icon
20
Canadian National Railway
CNI
$78.1B
$2.53M 1.73%
36,735
-100
-0.3% -$6.84K
PEP icon
21
PepsiCo
PEP
$191B
$2.52M 1.72%
26,600
-25
-0.1% -$2.4K
CELG
22
DELISTED
Celgene Corp
CELG
$2.49M 1.71%
22,290
– –
AAPL icon
23
Apple
AAPL
$4.93T
$2.44M 1.67%
88,248
-320
-0.4% -$8.71K
AMGN icon
24
Amgen
AMGN
$204B
$2.42M 1.65%
15,186
– –
ROK icon
25
Rockwell Automation
ROK
$51.2B
$2.21M 1.51%
19,855
– –
1
2 3 4 5

Similar funds

SIA
Spectrum Investment Advisors Mequon, Wisconsin $201M AUM 15.42% 1-Year Est. Return
LS
LCW Services Virginia Beach, Virginia $201M AUM
ACM
Ategra Capital Management Vienna, Virginia $201M AUM 23.33% 1-Year Est. Return
FB
First Bancorp Damariscotta, Maine $201M AUM 21.27% 1-Year Est. Return
MPM
Mountaineer Partners Management New York $201M AUM 106.11% 1-Year Est. Return
LWMI
Legacy Wealth Management (Idaho) Boise, Idaho $201M AUM 259.85% 1-Year Est. Return
RCM
Ridgepath Capital Management Knoxville, Tennessee $201M AUM 10.5% 1-Year Est. Return
CIG
Cairn Investment Group Vancouver, Washington $201M AUM 18% 1-Year Est. Return

Notis-McConarty Edward's Q4 2014 Portfolio in Review

As of Q4 2014, Notis-McConarty Edward held 120 positions worth $146M, up 3% from $142M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Notis-McConarty Edward's Q4 2014 filing shows 4 new, 17 increased, 19 reduced and 5 closed positions. Its largest new stake was CDK Global, Inc.: 16,070 shares worth $655K. The largest sale was GSK, an estimated $1.8M.

By sector, the portfolio is most concentrated in Healthcare at 23% of assets, down from 23% a quarter earlier, followed by Technology and Industrials.

  • Notis-McConarty Edward's largest Q4 2014 buy was CDK Global, Inc.: 16,070 shares worth $655K.
  • Notis-McConarty Edward added most to Helmerich & Payne in Q4 2014, an estimated $280K increase.
  • Notis-McConarty Edward's biggest Q4 2014 reduction was ExxonMobil, cutting an estimated $706K.
  • Notis-McConarty Edward fully exited GSK in Q4 2014, selling an estimated $1.8M.
  • Notis-McConarty Edward's ten largest holdings make up 31% of its $146M portfolio in Q4 2014.
  • Notis-McConarty Edward opened 4 new positions and closed 5 in Q4 2014.
  • Notis-McConarty Edward's portfolio value rose 3% quarter-over-quarter to $146M.

Based on Notis-McConarty Edward's 13F filing for Q4 2014, filed 13 Feb 2015.